A small town lawyer is forced to fight a giant pharmaceutical company and the FDA to try to save his daughter’s life in Thompson’s edgy legal thriller. When his lawsuit uncovers fraud and corruption, he is confronted with an enemy who will resort to bribery, kidnapping and murder to win. Learn about the book and this author, www.larrydthompson.com Mystery Thriller
Audi stellt ab dem 16. Mai am Wörthersee in Kärnten ein außerordentlich emotionales Sportgerät vor. Das Audi e-bike Wörthersee vereint Elektroantrieb und Muskelkraft. Design-Chef Wolfgang Egger: „Als High-Performance E-Bike für Sport und Tricks bündelt es die Audi-Kernkompetenzen design, ultra, e-tron und connect.“ Bei der diesjährigen Wörthersee-Tour, dem 31. Treffen der Audi-, VW-, Seat- und Skoda-Fans, hat das E-Bike seine Weltpremiere: Trial-Biker Julien Dupont und Downhill-Spezialistin Petra Bernhard demonstrieren ihre Stunt- und Streetbike-Fähigkeiten.
http://multivu.prnewswire.com/mnr/prne/audi/53820/
Provectus Pharmaceuticals, Inc. (OTC BB: PVCT, http://www.pvct.com), a development-stage oncology and dermatology biopharmaceutical company, has announced additional positive data from its Phase 2 clinical trial of PV-10 for metastatic melanoma. The data, on changes in visceral and nodal metastases following chemoablation of cutaneous melanoma lesions with PV-10, was presented by Dr.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/pvct/43978/
Boston Scientific Corporation (NYSE: BSX) announces positive clinical data from the Research in Severe Asthma (RISA) Trial, demonstrating the long-term safety of bronchial thermoplasty (BT) in patients treated with the Company’s AlairTM Bronchial Thermoplasty System. Follow-up data demonstrate that stable lung function is maintained and late clinical complications are absent over a five-year period in patients with severe refractory asthma treated with BT. Results were presented today at the annual European Respiratory Society (ERS) Congress in Amsterdam by Michel Laviolette, M.D., Professor of Medicine, Institut universitaire de cardiologie et de pneumologie at Université Laval in Québec City, Canada.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/bostonscientific/52128/
Jackie Carpenter, whose son was on trial after being framed for felony murder, had prayed for a miracle since his arrest but two days before the trial was asked by her son’s attorney not to bring her Bible into court. It took Jackie 10 months of building up her faith to become strong enough to choose between offending a juror or offending God. Carpenter appears regularly as a speaker at ladies’ retreats and Christian conferences. http://bit.ly/m1872S Media Contact: Book Publicist Scott Lorenz Book Marketing 734-667-2090 scottlorenz@westwindcos.com Christian
The largest-ever morbi-mortality study of treatments for chronic heart failure has shown that adding the specific heart rate lowering agent Procoralan® (ivabradine) to standard therapy significantly reduces the risk of death and hospitalisation for heart failure.1 Results from this new study, SHIFT (Systolic Heart Failure Treatment with the If Inhibitor Ivabradine Trial), were presented today at the European Society of Cardiology1 in Stockholm and published in The Lancet.2
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/shift/44195/
Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, reported that The New England Journal of Medicine today published results from Cohort B of The PARTNER Trial, which studied the Edwards SAPIEN transcatheter heart valve for the treatment of severe aortic stenosis. The results of the trial successfully met the primary endpoints of all-cause mortality and mortality plus repeat hospitalization.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/edwardslifesciences/44227/
Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced The New England Journal of Medicine has published results from the North American Phase 3 trial evaluating the safety and efficacy of the Company’s novel antibiotic fidaxomicin as a treatment for patients with Clostridium difficile infection (CDI). The Phase 3 trial showed that fidaxomicin significantly reduced recurrence rates and increased global cure rates when compared to vancomycin, the only treatment approved by the U.S. Food and Drug Administration for CDI. The article titled,
C. R. Bard, Inc. today announced the publication of RESILIENT trial results by Circulation: Cardiovascular Interventions showing the Bard LifeStent® Vascular Stent improved patency and reduced revascularization rates in patients with moderate-length lesions in the superficial femoral artery (SFA) and proximal popliteal artery compared to patients treated with percutaneous transluminal angioplasty (PTA).
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/bard/44623/
official website:
http://www.myspace.com/faintheartthemovie
Release Date: 26 September 2008 (UK)
Faintheart is directed by Vito Rocco and stars Eddie Marsan as Richard, a homestore employee with a nerdy passion for Viking re-enactments. However, when his latest battle causes him to be late for his father-in-law's funeral (and turn up in chain mail), his long suffering wife Cath (Jessica Hynes) realises she's had enough and begins a trial separation. Richard is convinced he can win Cath back, but he hasn't reckoned on the attentions of slimy PE teacher Gary (Paul Nicholls), who's also getting closer to Richard's son Martin (Tim Healy). Meanwhile, Richard's Star Trek obsessed best friend Julian (Ewen Bremner) begins a tentative relationship with the mother (Bronagh Gallagher) of a fellow Trekkie he met online.
official website:
http://www.myspace.com/faintheartthemovie
Release Date: 26 September 2008 (UK)
Faintheart is directed by Vito Rocco and stars Eddie Marsan as Richard, a homestore employee with a nerdy passion for Viking re-enactments. However, when his latest battle causes him to be late for his father-in-law's funeral (and turn up in chain mail), his long suffering wife Cath (Jessica Hynes) realises she's had enough and begins a trial separation. Richard is convinced he can win Cath back, but he hasn't reckoned on the attentions of slimy PE teacher Gary (Paul Nicholls), who's also getting closer to Richard's son Martin (Tim Healy). Meanwhile, Richard's Star Trek obsessed best friend Julian (Ewen Bremner) begins a tentative relationship with the mother (Bronagh Gallagher) of a fellow Trekkie he met online.
